The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response yesterday announced a $9.3 million contract to develop a test that could help hospital and commercial laboratories speed diagnosis of bacterial infections and determine the best antibiotics to treat them. ASPR’s Biomedical Advanced Research and Development Authority will sponsor advanced development of the testing technology under an 18-month contract with SeLux Diagnostic Inc. The agency said the technology aims to reduce the time needed to diagnose bacterial infections from days to hours and curb antibiotic-resistant infections.

Headline
The Food and Drug Administration Aug. 5 approved the first mRNA-based flu vaccine, called mFlusiva. The vaccine is manufactured by Moderna and was approved for…
Headline
Two individuals have died in Michigan in connection to the current multistate cyclosporiasis outbreak, the Michigan Department of Health and Human Services…
Headline
There have been 2,318 confirmed measles cases in the U.S. so far this year, the most in the country since 1991, according to the latest data from the…
Headline
The AHA’s Living Learning Network, in partnership with the Centers for Disease Control and Prevention, July 22 released “Rural Sepsis Care in Action: Real-…
Headline
A Centers for Disease Control and Prevention report released July 16 found that wastewater surveillance failed to detect an internationally circulating measles…
Headline
The Centers for Disease Control and Prevention July 14 released an advisory on the growing cyclosporiasis cases across the U.S. The advisory said that the…